Lonza Group reported CHF699M in EBIT for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Akzo Nobel AKZA:NA EUR 152M 13M
Alcon AG ALC:SW USD 222M 36M
AstraZeneca AZN:LN USD 2.26B 427M
Bayer BAYN:GR EUR 1.35B 928M
Covestro 1COV:GR EUR 66M 241M
Fresenius FRE:GR EUR 845M 54M
Fresenius Medical Care FME:GR EUR 269M 53M
Genmab GEN:DC DKK 1.93B 684M
Givaudan GIVN:VX CHF 625M 138M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Hikma Pharmaceutical HIK:LN USD 256M 23M
Johnson Matthey JMAT:LN GBP 220M 33M
Merck MRK:GR EUR 1.35B 3M
Novartis NOVN:VX USD 3.33B 8M
Philips PHIA:NA EUR 105M 30M
Roche Holding ROG:VX 11.54B 2.84B
Smith & Nephew PLC SN/:LN 335M 57M
Solvay SOLB:BB EUR 634M 300M
William Demant Holding WDH:DC DKK 1.53B 297M